Mersana

FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mon, 03/13/23 - 10:54 am
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
antibody-drug conjugate
Merck
LegoChem Biosciences
Mersana
Amgen
GSK
Janssen
GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep
Fierce Biotech
Mon, 08/8/22 - 11:45 pm
GSK
Mersana
antibody-drug conjugate
Blenrep
XMT-2056
J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets
Fierce Biotech
Thu, 02/3/22 - 11:18 am
JNJ
Janssen
Mersana
antibody-drug conjugate
biobucks
Mersana starts to lose its shine
EP Vantage
Wed, 01/6/21 - 10:38 am
Mersana
ovarian cancer
XMT-1536
antibody-drug conjugate
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
FDA lifts clinical hold from Mersana’s breast cancer trial
Fierce Biotech
Mon, 09/17/18 - 09:46 am
FDA
clinical trials
Mersana
antibody-drug conjugate
XMT-1522
breast cancer
Patient death prompts FDA hold on Mersana’s lead cancer ADC
Fierce Biotech
Sat, 07/21/18 - 12:14 am
Mersana
XMT-1522
antibody-drug conjugate
patient deaths
clinical trials
After billion-dollar drug deal, patient death and trial hold cripple Mersana’s shares
Endpoints
Thu, 07/19/18 - 09:49 am
Mersana
patient deaths
XMT-1522
Another biotech IPO boasting a pharma castoff rings the bell on Wall Street with $75M haul
Endpoints
Thu, 06/29/17 - 02:22 pm
IPOs
biotech
Dova Pharmaceuticals
Mersana
Aileron
Teva licenses Mersana cancer treatment for $334M
Yahoo/AP
Wed, 04/14/10 - 09:13 am
Teva Pharmaceuticals
Mersana
cancer
liscensing